Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Patricia learned early in her career that nothing creative can grow in a negative working environment. But she didn’t let that stand in her way. Now a leader in academia, she is determined to play her part in changing that culture.

Patricia Kingori smiling outdoors

Patricia's research career nearly stalled halfway through her PhD.

Civil unrest had forced her to leave Kenya, where she was doing her fieldwork, at short notice. That put her under pressure to work out how to continue her research. 

"Everything started to feel like it was falling apart. Kenya was the main location for my PhD and it didn’t look like I was going to be able to go back safely." 

She was also pregnant with her second child – and felt unsupported at work.

"My time away on maternity leave had really been seen as writing me off. ‘That’s it now, we might never see her again,’ that kind of attitude. I found that very difficult.

This wasn’t what Patricia had expected from her PhD. She’d hardly rushed into it – for eight years she’d worked as a research assistant and then as a research fellow at two London universities.

Read the full story (Wellcome Trust website)

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.